Big Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 18.77%
- Profit Growth -1.38%
- Ebitda 356.93%
- Net Worth 55.24%
- Total Assets 19.13%
About Big Laboratories
Big Laboratories Private Limited (BLPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 July 2014 and has a history of Ten years and six months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nitu Kumari and Mamta Kumari serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33125DL2014PTC269005
-
Company No.
269005
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jul 2014
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Big Laboratories Private Limited offer?
Big Laboratories Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules.
Who are the key members and board of directors at Big Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitu Kumari
|
Director | 17-Jul-2014 | Current |
|
Mamta Kumari
|
Director | 06-Jul-2021 | Current |
Financial Performance of Big Laboratories.
Big Laboratories Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 18.77% increase. The company also saw a slight decrease in profitability, with a 1.38% decrease in profit. The company's net worth Soared by an impressive increase of 55.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Big Laboratories?
In 2018, Big Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Astagenix Laboratories Private LimitedNitu Kumari is a mutual person
-
Big Labs Private Limited
Nitu Kumari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Big Laboratories?
Unlock and access historical data on people associated with Big Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Big Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Big Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
